IRCT1138901221180N13已完成2 期
Comparison of Intravitreal Bevacizumab and Triamcinolone with Placebo in Acute Nonarteritic Anterior Ischemic Optic Neuropathy
Ophthalmic Research Center0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •sudden mono ocular vision loss associated with optic disc edema and positive Marcus Gunn (<30 days). Exclusion criteria: any eye disease except NAION (Nonarteritic Anterior Ischemic Optic Neuropathy), neurologic defect, abnormal ESR, CRP, any history of retina or vitrea surgery, severe corneal opacity which makes retina examination impossible.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCentral Retinal Vein Occlusion With Macular EdemaNCT04812977Hayatabad Medical Complex30
已完成
不适用
Intra ocular injection of Bevacizumab and Triamcinolone for diabetic visual loss.CTRI/2014/09/005070ethradhama Superspeciality Eye Hospita15
已完成
3 期
Comparative Efficacy of Intravitreal Bevacizumab and Topical Diclofenac Combined Therapy, Intravitreal Ketorolac, and Intravitreal Bevacizumab on Diabetic Macular Edemadiabetic macular edemaEye - Diseases / disorders of the eyeMetabolic and Endocrine - Diabetesdiabetes mellitusACTRN12622000313730Supanji Haryanto82
Unknown
3 期
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialDiabetic Macular EdemaNCT00370422Shahid Beheshti University of Medical Sciences
已完成
不适用
Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularizatioJPRN-UMIN000008588Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele50